Clinical Trials Logo

Benign Thyroid Nodule clinical trials

View clinical trials related to Benign Thyroid Nodule.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06014229 Recruiting - Clinical trials for Benign Thyroid Nodule

Cryoablation and RFA of Benign Thyroid Nodules: Pilot Study

Start date: August 25, 2023
Phase: N/A
Study type: Interventional

This study will evaluate the clinical response and safety of ultrasound guided percutaneous cryoablation and a radiofrequency ablation in the treatment of benign thyroid nodules as an alternative to the surgery. Ablation of benign thyroid nodules with cryoablation will be directed to patients with benign thyroid lesions (two benign cytological examinations) measuring between 5 and 65 mL of volume and less than 40% of cystic component; patients must present with serum free thyroxine (T4) and thyroid stimulating hormone (TSH) between the normal range values, with no signs of thyroiditis by serum antibodies over 100% of the standard values; calcitonin levels in the normal range values. The cryoablation or RFA will be directed in a non-randomized fashion. Clinical, laboratorial and imaging monitoring will be performed in 12 months, including contrast-enhanced ultrasound when indicated, by 1, 3, 6 and 12 months.